Daclatasvir - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Antiviral drug Imidazole Withdrawn drug World Health Organization essential medicine owl:NamedIndividual Carbamate Pyrrolidine NS5A inhibitor Biphenyl
rdfs:label	Daclatasvir
owl:sameAs	dbr:Daclatasvir
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Biphenyls http://en.wikipedia.org/wiki/Category:Withdrawn_drugs http://en.wikipedia.org/wiki/List_of_withdrawn_drugs http://en.wikipedia.org/wiki/Category:NS5A_inhibitors http://en.wikipedia.org/wiki/Category:Carbamates http://en.wikipedia.org/wiki/Category:Pyrrolidines http://en.wikipedia.org/wiki/Category:Imidazoles http://en.wikipedia.org/wiki/Category:World_Health_Organization_essential_medicines http://en.wikipedia.org/wiki/List_of_antiviral_drugs http://en.wikipedia.org/wiki/WHO_Model_List_of_Essential_Medicines http://en.wikipedia.org/wiki/Bristol_Myers_Squibb
skos:prefLabel	Daclatasvir
skos:altLabel	Daclavir daclatasvir
clgo:alternativeName	Daklinza
clgo:bioavailability	67.0
clgo:casNumber	1009119-64-5
clgo:chEBI	82977
clgo:drugbank	DB09102
clgo:fdaUniiCode	LI2427F9CI
clgo:kegg	D10065 D10105
clgo:medlinePlus	a615044
clgo:pubchem	25154714
is clgo:product of	Beacon Pharmaceuticals

About: clgr:Daclatasvir